The company manages raw materials, drug substances, and finished drug products for studies and trials, utilizing internal resources for third-party manufacturing. It holds a license agreement with Anacor Pharmaceuticals, Inc. (the Anacor Agreement), which grants exclusive and non-exclusive rights to use, develop, manufacture, and commercialize certain compounds, including epetraborole. The agreement provides for upfront payments, milestone payments, and tiered sales royalties to Anacor based on net sales in various countries. Royalties are payable until the later of 15 years from the first sale, expiration of exclusivity, or patent expiration, with the last valid patent claim for epetraborole expiring in June 2028. Additionally, Anacor is entitled to milestone payments upon a change of control of the company. Anacor Pharmaceuticals, Inc. is identified as a supplier in company filings.
An2 Therapeutics Inc's Comment on Supply Chain
The company manages raw materials, drug substances, and finished drug products for studies and trials, utilizing internal resources for third-party manufacturing. It holds a license agreement with Anacor Pharmaceuticals, Inc. (the Anacor Agreement), which grants exclusive and non-exclusive rights to use, develop, manufacture, and commercialize certain compounds, including epetraborole. The agreement provides for upfront payments, milestone payments, and tiered sales royalties to Anacor based on net sales in various countries. Royalties are payable until the later of 15 years from the first sale, expiration of exclusivity, or patent expiration, with the last valid patent claim for epetraborole expiring in June 2028. Additionally, Anacor is entitled to milestone payments upon a change of control of the company. Anacor Pharmaceuticals, Inc. is identified as a supplier in company filings.
Sources:
An2 Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on An2 Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
